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Gillian M Hunt AS-PCR is designed such that the terminal 3'-nucleotide of a primer is allele-specific, 89 allowing for sequence scrutiny at a point mutation polymorphism [9] using real-time PCR 90 apparatus. The system is advantageous in that it is fast, inexpensive and can detect mutant 91 species at frequencies below 1% [7] , but is limited by its requirement for adequate 92 knowledge of the extent of sequence variation at the nucleotide site of interest for its 93 application. 94 95 K103N and Y181C are the major nucleoside reverse transcriptase inhibitors (NNRTI) 96 mutations selected under nevirapine (NVP) prophylaxis which is still used in low 97 resource settings as a core component of interventions to prevent mother-to-child HIV-1 98 transmission (pMTCT) [10, 11] . We previously showed a high prevalence of age-related 99 NNRTI resistance mutations persisting among infants and children as a result of exposure 100 to single-dose nevirapine (sdNVP) prior to start of antiretroviral treatment (ART) with a 101 protease inhibitor-based regimen [4, 12] were included in the analysis of concordance between the two genotyping approaches 133 (n=105). Thirty-six specimens were excluded from analysis for the following reasons: 12 134 specimens had viral loads that were too low for UDPS (<100,000 copies/mL) at the time 135 of study [2] , UDPS failed in 7 specimens, the Y181C AS-PCR was not successful in 2 136 specimens, 1 specimen had a false positive Y181C AS-PCR due to a Y181FS 137 polymorphism, and phylogenetic relatedness between plasma sequences from both labs 138 and UDPS consensus sequences was not confirmed in 14 specimens. 139 140 141
Frequency of Y181C and K103N mutant detection using different technologies 142
The total number of samples where the Y181C and K103N mutations were detected by 143 population sequencing, AS-PCR and UDPS are shown in Table 1A . Given that 144 population sequencing generally only detects mutant populations when they appear in 145 more than 20% of the quasispecies we chose this cut-off to categorize data from AS-PCR 146 and UDPS as high (>20%) or low (<20%). Y181C was detected by population 147 sequencing in 22 of 105 (21%) specimens. All of these plus an additional 6 infants were 148 positive by the Y181C AS-PCR (mean quantitative percentage value measure 149 (µ)=43.28%). Of these 28 AS-PCR positives (28/105, 27%), 19 were considered at a high 150 level (20.11% -99.97%; µ=69.99%) and 9 at low levels (0.65% -16.03%; µ=5.65%). 151
Slightly fewer samples, 25/105 (24%) were detected by UDPS, 16 at high levels (25.37% 152 -99.73%; µ=67.70%) and 9 at low levels (1.30% -19.60%; µ=13.40%). 153
154
The K103N mutation was detected in 4 infants (4%) by population sequencing, in 9 155 infants (9%) by AS-PCR (4 at high levels [20.56% -99.93%; µ=69.70%] and 5 at low 156 levels [0.60% -15.06%; µ=1.14%]), and in 8 specimens by UDPS (8%; 3 at high levels 157 (31.38% -99.60%; µ=82.60%) and 5 at low levels (1.00% -14.62%; µ=1.80%)). Overall 158 these data confirm the increased sensitivity of low-frequency drug resistance assays over 159 standard genotyping. These data also confirm the higher prevalence of Y181C relative to 160 K103N in infants who receive sdNVP for pMTCT. 161 162 A comparison of qualitative outcome (i.e. positive or negative for mutation detection) 163 between AS-PCR and UDPS for each loci was performed using a contingency analysisfor which a kappa statistic was also calculated (Table 1B) 
Analysis of discordance between AS-PCR and UDPS 191
The samples that were discordant for Y181C or K103N between the 2 technologies were 192 further investigated (Table 2 ). Five specimens were discordant for Y181C and 11 for 193 K103N. There was no overlap in 14 samples in that discordance for one mutation did not 194 yield discordance for the other. One sample was discordant in both assays (Sample #7). The majority of discordant specimens had concentrations of mutant virus that were close 242 to the limit of detection of each assay, suggesting that detection of minor variants were 243 due to stochastic variations in the appearance of each mutant in each of specimens tested. 244
Five specimens showed significant levels of non-correlation, two for Y181C and three for 245 K103N. Appropriate quality assurance procedures were followed in conducting both 246 
